On the double-robustness and semiparametric efficiency of matching-adjusted indirect comparisons

被引:5
|
作者
Cheng, David [1 ]
Tchetgen, Eric Tchetgen [2 ]
Signorovitch, James [3 ]
机构
[1] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA
[2] Univ Penn, Wharton Sch, Dept Stat & Data Sci, Philadelphia, PA USA
[3] Anal Grp Inc, Boston, MA USA
基金
美国国家卫生研究院;
关键词
health technology assessment; indirect comparison; MAIC; simulated treatment comparison;
D O I
10.1002/jrsm.1616
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Matching-adjusted indirect comparison (MAIC) enables indirect comparisons of interventions across separate studies when individual patient-level data (IPD) are available for only one study. Due to its similarity with propensity score weighting, it has been speculated that MAIC can be combined with outcome regression models in the spirit of augmented inverse probability weighting estimators to improve robustness and efficiency. We show that MAIC enjoys intrinsic double-robustness and semiparametric efficiency properties for estimating the average treatment effect on the treated in the limited IPD setting without explicit augmentation. A connection between MAIC and the method of simulated treatment comparisons is highlighted. These results clarify conditions under which MAIC is consistent and efficient, informing appropriate application and interpretation of MAIC analyses.
引用
收藏
页码:438 / 442
页数:5
相关论文
共 50 条
  • [31] THE USE OF MATCHING-ADJUSTED INDIRECT COMPARISON FOR ONCOLOGY SUBMISSIONS IN NICE
    Kaur, G.
    Singh, B.
    VALUE IN HEALTH, 2023, 26 (12) : S407 - S407
  • [32] EVALUATION OF MATCHING-ADJUSTED INDIRECT COMPARISON IMPLEMENTED BY A RESAMPLING METHOD
    Wang, J.
    Odom, D.
    Chirila, C.
    Zheng, Q.
    VALUE IN HEALTH, 2015, 18 (03) : A31 - A31
  • [33] Correction: Two-stage matching-adjusted indirect comparison
    Antonio Remiro‑Azócar
    BMC Medical Research Methodology, 22
  • [34] Effect modification in anchored indirect treatment comparison: Comments on "Matching-adjusted indirect comparisons: Application to time-to-event data"
    Remiro-Azocar, Antonio
    Heath, Anna
    Baio, Gianluca
    STATISTICS IN MEDICINE, 2022, 41 (08) : 1541 - 1553
  • [35] Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy
    Wong, Emily C. L.
    Dulai, Parambir S.
    Marshall, John K.
    Jairath, Vipul
    Reinisch, Walter
    Narula, Neeraj
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (02) : 311 - 313
  • [36] Generalizing some key results from "alternative weighting schemes when performing matching-adjusted indirect comparisons"
    Zhang, Landan
    Jackson, Dan
    RESEARCH SYNTHESIS METHODS, 2024, 15 (01) : 152 - 156
  • [37] Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity Disorder
    Shafrin, Jason
    Shrestha, Anshu
    Chandra, Amitabh
    Erder, M. Haim
    Sikirica, Vanja
    HEALTH ECONOMICS, 2017, 26 (11) : 1459 - 1466
  • [38] The Importance of Clinical Context and Consistency in Methodology When Using Matching-Adjusted Indirect Comparisons (MAICs) to Compare Outcomes
    Batt, Katharine
    Klamroth, Robert
    Mancuso, Maria Elisa
    Tiede, Andreas
    Mantovani, Lorenzo G.
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 3927 - 3932
  • [39] Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis
    Lu, Xiaoyan
    Zhou, Zheng-Yi
    Xin, Yiqiao
    Wang, Min-Jung
    Gray, Emma
    Jairath, Vipul
    Lindsay, James Oliver
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (01) : 64 - 77
  • [40] Matching-Adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Ibrutinib in Relapsed/ Refractory Mantle Cell Lymphoma
    Gaitonde, Priyanka
    Cai, Ling
    de Miranda, Paulo
    Roos, Jack
    Rule, Simon
    Wang, Michael L.
    BLOOD, 2022, 140 : 3646 - 3647